A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Phase of Trial: Phase III
Latest Information Update: 05 Sep 2019
Price : $35 *
At a glance
- Drugs Ribociclib (Primary) ; Letrozole
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 28 Aug 2019 Status changed from completed to discontinued.
- 23 May 2019 Status changed from active, no longer recruiting to completed.
- 23 Jan 2019 Status changed from recruiting to active, no longer recruiting.